BR112012027574A2 - aparelho e kit de encapsulação de pelo menos um composto para uso terapêutico e/ou em diagnóstico em eritrócitos - Google Patents

aparelho e kit de encapsulação de pelo menos um composto para uso terapêutico e/ou em diagnóstico em eritrócitos

Info

Publication number
BR112012027574A2
BR112012027574A2 BR112012027574A BR112012027574A BR112012027574A2 BR 112012027574 A2 BR112012027574 A2 BR 112012027574A2 BR 112012027574 A BR112012027574 A BR 112012027574A BR 112012027574 A BR112012027574 A BR 112012027574A BR 112012027574 A2 BR112012027574 A2 BR 112012027574A2
Authority
BR
Brazil
Prior art keywords
erythrocytes
encapsulating
kit
therapeutic
compound
Prior art date
Application number
BR112012027574A
Other languages
English (en)
Other versions
BR112012027574B1 (pt
Inventor
Mambrini Giovanni
Serafini Sonja
Original Assignee
Erydel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erydel Spa filed Critical Erydel Spa
Publication of BR112012027574A2 publication Critical patent/BR112012027574A2/pt
Publication of BR112012027574B1 publication Critical patent/BR112012027574B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
    • A61M1/3633—Blood component filters, e.g. leukocyte filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3692—Washing or rinsing blood or blood constituents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0429—Red blood cells; Erythrocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112012027574-7A 2010-04-26 2011-04-26 aparelho de introdução de pelo menos um composto em eritrócitos, kit descartável para o aparelho e dispositivo reutilizável BR112012027574B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITBO2010A000255 2010-04-26
ITBO2010A000255A IT1399590B1 (it) 2010-04-26 2010-04-26 Apparato e kit per incapsulare almeno un composto ad uso terapeutico e/o diagnostico all'interno di eritrociti
US37301810P 2010-08-12 2010-08-12
US61/373,018 2010-08-12
PCT/IB2011/000891 WO2011135429A1 (en) 2010-04-26 2011-04-26 Apparatus and kit for encapsulating at least one compound for therapeutic and/or diagnostic use in erythrocytes

Publications (2)

Publication Number Publication Date
BR112012027574A2 true BR112012027574A2 (pt) 2017-08-08
BR112012027574B1 BR112012027574B1 (pt) 2021-05-18

Family

ID=43530507

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012027574-7A BR112012027574B1 (pt) 2010-04-26 2011-04-26 aparelho de introdução de pelo menos um composto em eritrócitos, kit descartável para o aparelho e dispositivo reutilizável

Country Status (17)

Country Link
US (1) US9089640B2 (pt)
EP (1) EP2563343B1 (pt)
JP (1) JP2013527165A (pt)
KR (1) KR101794375B1 (pt)
CN (1) CN102985079B (pt)
AU (1) AU2011247018B2 (pt)
BR (1) BR112012027574B1 (pt)
CA (1) CA2797194C (pt)
DK (1) DK2563343T3 (pt)
ES (1) ES2634987T3 (pt)
IL (1) IL222605A (pt)
IT (1) IT1399590B1 (pt)
MX (1) MX2012012346A (pt)
PL (1) PL2563343T3 (pt)
RU (1) RU2595844C2 (pt)
SG (1) SG185018A1 (pt)
WO (1) WO2011135429A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9518087B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
ITRM20130280A1 (it) * 2013-05-10 2014-11-11 Erydel Spa Procedimento per la preparazione di eritrociti caricati con una o più sostanze di interesse farmaceutico.
ES2950419T3 (es) * 2013-05-10 2023-10-09 Erydel Spa Procedimiento para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos obtenidos de esta manera
ES2874884T3 (es) 2014-02-21 2021-11-05 Ecole Polytechnique Fed De Lausanne Epfl Epfl Tto Compuestos terapéuticos dirigidos a la glucosa
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
JP6628748B2 (ja) * 2014-06-17 2020-01-15 ライフ テクノロジーズ コーポレーション 配列決定デバイス
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
JP2021536295A (ja) * 2018-09-11 2021-12-27 ヘモネティクス・コーポレーションHaemonetics Corporation 細胞処理プロトコル生成システムおよび方法
WO2023027613A1 (ru) * 2021-08-27 2023-03-02 Общество С Ограниченной Ответственностью "Рбк-Фармэко" Устройство и способ для включения биологически активных компонентов в эритроциты способом проточного диализа
IT202100023375A1 (it) * 2021-09-09 2023-03-09 Yang Shunfa Dispositivo per la produzione di vescicole bioingegnerizzate dedicate e metodo correlato

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2326244C3 (de) 1973-05-23 1980-10-02 Kernforschungszentrum Karlsruhe Gmbh, 7500 Karlsruhe Anlage zur Vorbereitung, Wägung und Weiterleitung einer Probe
DE2326161C2 (de) 1973-05-23 1986-07-17 Kernforschungsanlage Jülich GmbH, 5170 Jülich Verfahren zum Aufbau oder zum Abbau von durch chemische Eigenschaften ausgezeichneten, in einer wäßrigen Lösung enthaltenen Stoffen
GB1481480A (en) 1974-02-02 1977-07-27 Kernforschungsanlage Juelich Process and apparatus for increasing the permeability of the membrane of cells of organisms
DE2655801C2 (de) 1976-12-09 1986-06-26 Kernforschungsanlage Jülich GmbH, 5170 Jülich Injizierbare Suspension von Membranvesikeln aus Erythrozyten und Verfahren zur Herstellung der Suspension
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
US4478824A (en) 1983-08-08 1984-10-23 Franco Robert S Method for altering red blood cell function and survival
US4931276A (en) 1987-10-30 1990-06-05 Franco Robert S Method for introducing desired agents into red blood cells
FR2678512B1 (fr) * 1991-07-03 1995-06-30 Novacell Machine a internaliser.
EP0690671B1 (en) * 1993-03-23 2004-08-04 Cbr Laboratories, Inc. Method and apparatus for encapsulation of biologically-active substances in cells
EP0882448B1 (en) * 1997-05-05 2005-01-12 DIDECO S.r.l. Method of encapsulating biologically active agents within erythrocytes and apparatus therefor
JP3944279B2 (ja) * 1997-06-16 2007-07-11 テルモ株式会社 血液成分採取装置
GB0002856D0 (en) * 2000-02-08 2000-03-29 Gendel Limited Ultrasound sensitisation
JP2008067779A (ja) * 2006-09-12 2008-03-27 Terumo Corp 血液成分採取装置、ディスポーザブルユニット及び装置本体
ATE536195T1 (de) * 2007-10-04 2011-12-15 Gambro Lundia Ab Infusionsgerät

Also Published As

Publication number Publication date
US9089640B2 (en) 2015-07-28
CA2797194A1 (en) 2011-11-03
CA2797194C (en) 2019-07-09
DK2563343T3 (en) 2017-08-21
KR20130118728A (ko) 2013-10-30
EP2563343A1 (en) 2013-03-06
CN102985079A (zh) 2013-03-20
CN102985079B (zh) 2014-10-15
KR101794375B1 (ko) 2017-11-06
ITBO20100255A1 (it) 2011-10-27
AU2011247018A1 (en) 2012-11-15
IL222605A0 (en) 2012-12-31
IT1399590B1 (it) 2013-04-26
RU2595844C2 (ru) 2016-08-27
BR112012027574B1 (pt) 2021-05-18
PL2563343T3 (pl) 2017-10-31
WO2011135429A1 (en) 2011-11-03
RU2012150267A (ru) 2014-06-10
AU2011247018B2 (en) 2014-11-27
SG185018A1 (en) 2012-11-29
ES2634987T3 (es) 2017-10-02
US20130101463A1 (en) 2013-04-25
EP2563343B1 (en) 2017-05-31
JP2013527165A (ja) 2013-06-27
IL222605A (en) 2016-11-30
MX2012012346A (es) 2013-03-05

Similar Documents

Publication Publication Date Title
BR112012027574A2 (pt) aparelho e kit de encapsulação de pelo menos um composto para uso terapêutico e/ou em diagnóstico em eritrócitos
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BR112014019750A8 (pt) composto, composlção farmacêutlca, método para aumentar a lnclusão de éxon 7 de smn2 em mrna, método para aumentar a quantidade de proteína smn e método para tratar sma em um indivíduo humano em necessidade
BR112012031232A2 (pt) método, dispositivo e uso
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
BR112012022878A2 (pt) composto, composição farmacêutica, uso do compostos e método de tratamento
BR112013010988A2 (pt) composição fluída e uso
BR112013010272A2 (pt) métodos analíticos e arranjos para uso nos mesmos
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
BR112012001797A2 (pt) composto bicíclico e uso do mesmo para propósitos médicos
BRPI0921997A2 (pt) dispositivo para medição do componente de sangue.
BR112013001423A2 (pt) método, método in vitro, uso e kit útil para realizar o método
BR112015002706A2 (pt) niclosamida e seus derivados para uso no tratamento de tumores sólidos
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BR112012016229A2 (pt) método para melhorar a sobrevida livre de progressão, método in vitro, kit, uso de um oligonucleotídeo ou polipetídeo e uso de bevacizumab
BRPI0919794A2 (pt) dispositivo para uso intracorpóreo, e, composto
BR112014029642A2 (pt) composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BR112012030927A2 (pt) fosfaplatinas e seu uso para o tratamento de cânceres
BR112013007614A2 (pt) método para medir um analito em uma amostra, composição, mistura, uso e kit
BR112013012175A2 (pt) combinação, coadministração, uso e método
BR112013023575A2 (pt) “derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes”
BR112013028894A2 (pt) composto de tiazol, métodos para preparação e uso do mesmo
BR112012029824A2 (pt) métodos para o preparo de cloreto de glicopirrônio, cloreto de glicopirrônio, composição farmacêutica e uso de cloreto de glicopirrônio

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B25G Requested change of headquarter approved

Owner name: ERYDEL S.P.A. (IT)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/04/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF